ChartRow logo
GRDN
$41.87+4.31%
as of close, Oct 20, 2026
☾ AH $41.87 +4.31%
PeersMRNALLYMDTUNHJNJTMO
Share this page

GRDN financial statements

The full income statement, balance sheet, and cash-flow statement for Guardian Pharmacy Services Inc. (GRDN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024
Income Statementas ofDec 31 ’25as ofDec 31 ’24
Revenue1.45B+17.9%1.23B
293M+19.8%244M
Cost of revenue1.16B+17.5%984M
Selling, general & administrative220M-28.4%307M
Provision for credit losses4.58M-28.1%6.37M
Operating income72.7M+215.5%-62.9M
Interest expense665K-79.7%3.28M
Other non-operating income1.39M+597.1%-279K
Pre-tax income73.4M+210.4%-66.5M
Income tax24.5M+437.0%4.56M
49.2M+144.7%-110M
Net income to non-controlling interest-261K-101.6%16.3M
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24
222M+45.8%152M
Cash & equivalents65.6M+1308.1%4.66M
Accounts receivable102M+4.6%97.2M
Inventory43.4M+6.9%40.5M
Other current assets11.0M+14.8%9.62M
413M+28.6%321M
Property, plant & equipment55.5M+11.3%49.9M
Operating lease right-of-use34.6M+19.2%29.1M
Goodwill79.7M+15.1%69.3M
Intangible assets18.5M+23.9%14.9M
Deferred tax assets2.20M-58.3%5.27M
Other non-current assets436K+13.8%383K
161M+11.5%144M
Accounts payable116M+13.5%102M
Current lease liability7.15M+4.6%6.84M
Other current liabilities22.3M+9.1%20.4M
Finance lease liability (current)3.88M+2.6%3.78M
195M+14.0%171M
Long-term debt0.000.00
Non-current lease liability30.0M+28.7%23.3M
Finance lease liability3.70M+8.4%3.42M
Other non-current liabilities4.04M+18.2%3.42M
218M+45.3%150M
Additional paid-in capital139M+11.1%125M
Retained earnings66.3M+287.4%17.1M
Non-controlling interest12.2M+66.5%7.30M
Total equity incl. non-controlling218M+45.3%150M
Total liabilities & equity413M+28.6%321M
Cash Flowas ofDec 31 ’25as ofDec 31 ’24
100M+73.0%58.0M
Depreciation & amortization22.3M+13.0%19.8M
Share-based compensation13.8M-89.5%131M
Deferred income taxes
3.07M—
Change in receivables8.55M-66.4%25.5M
Change in inventory877K-23.8%1.15M
Change in payables16.4M+23.9%13.2M
-32.2M-6.0%-30.4M
Capital expenditure13.4M-8.8%14.7M
Free cash flow86.8M+100.8%43.3M
Acquisitions0.000.00
-7.07M+70.1%-23.6M
Long-term debt issued0.000.00
Long-term debt repaid0.000.00
Common stock issued29.0M-75.8%120M
Common stock repurchased0.00-100.0%55.2M
Dividends paid0.000.00
Net change in cash61.0M+1459.9%3.91M
Interest paid650K-79.2%3.12M
Income taxes paid21.5M0.00
Source filing10-K10-K

About this data

Source: GRDN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GRDN filings on SEC EDGAR → Not investment advice.